- She Built Greenvolt’s U.S. Operations from Nothing. Now the Industry Is Taking Notice.
Most career stories about renewable energy leadership involve someone joining an established team, inheriting an existing pipeline, and growing from there. Weronika Bianka Nowak’s story is different. When she joined Greenvolt Power USA, there was no team to join. There was no pipeline to inherit. There was no office, no local market knowledge, no existing… Read more: She Built Greenvolt’s U.S. Operations from Nothing. Now the Industry Is Taking Notice. - Cerebri AI Is Building the Intelligence Layer That Corporate Travel Has Always Needed
There is a persistent gap between how companies think they are spending on corporate travel and how they are actually spending on it. The gap exists not because finance teams are careless, but because the data that would close it is scattered across systems that were never designed to talk to each other. A booking… Read more: Cerebri AI Is Building the Intelligence Layer That Corporate Travel Has Always Needed - The $300 Billion Patent Cliff Is Coming for Big Pharma and Workforce Strategy Will Define Who Survives
Some crises arrive without warning. The pharmaceutical industry’s patent cliff is not one of them. The expiration dates on blockbuster drugs are filed publicly with the USPTO. The revenue exposure has been calculable for years. The window between now and 2030, during which more than $300 billion in branded prescription drug revenue will lose exclusivity… Read more: The $300 Billion Patent Cliff Is Coming for Big Pharma and Workforce Strategy Will Define Who Survives